Yuki Ozaki
- Biological Psychiatry top 10%
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms 3
-
- Alzheimer's disease research and treatments 8
-
- Cancer Immunotherapy and Biomarkers 8
- Lung Cancer Research Studies 5
-
- Lung Cancer Treatments and Mutations 6
- Lung Cancer Diagnosis and Treatment 3
-
- Neuroendocrine Tumor Research Advances 5
-
- Epigenetics and DNA Methylation 3
Yuki Ozaki
38 papers receiving 477 citations
Peers
Comparison fields: 5 of 72
- Biological Psychiatry 33
- Neurology 100
- Physiology 161
- Oncology 96
- Psychiatry and Mental health 53
Countries citing papers authored by Yuki Ozaki
This map shows the geographic impact of Yuki Ozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Ozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Ozaki more than expected).
Fields of papers citing papers by Yuki Ozaki
This network shows the impact of papers produced by Yuki Ozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Ozaki. The network helps show where Yuki Ozaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuki Ozaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 2 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 3 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 0 | |
| 10 | 2021 | 0 | |
| 11 | 2021 | 16 | |
| 12 | 2020 | 3 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 5 | |
| 15 | 2019 | 36 | |
| 16 | 2018 | 9 | |
| 17 | 2018 | 12 | |
| 18 | 2017 | 68 | |
| 19 | 2017 | 34 | |
| 20 | 2016 | 15 |
About Yuki Ozaki
Yuki Ozaki is a scholar working on Biological Psychiatry, Oncology and Neurology, having authored 40 papers that have together received 483 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (6 papers), Neuroendocrine Tumor Research Advances (5 papers), Lung Cancer Research Studies (5 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Biological Psychiatry (33 citations), Neurology (100 citations) and Physiology (161 citations). Yuki Ozaki has collaborated with scholars based in Japan. Frequent co-authors include Shuichi Ueno, Jun‐ichi Iga, Kiyohiro Yamazaki, Yuta Yoshino, Shinichiro Ochi, Takaaki Mori, Tomoko Sao, Taku Yoshida, Yoko Mori and Yoko Mori. Their work appears in journals such as Scientific Reports, International Journal of Heat and Mass Transfer and Psychiatry Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.